Today is NF2 Awareness Day and NF2 BioSolutions UK & Europe has incredible news for all those affected by NF2!

NF2 BioSolutions UK & Europe, together with NF2 BioSolutions, are excited to announce a new transatlantic partnership with researchers at the newly opened Geoffrey Jefferson Brain Research Centre (GJBRC) to support research into the role of inflammation in NF2 tumour growth (Schwannomas and Meningiomas)

There is a real potential that this research will lead to new treatments for those affected by NF2 by repurposing existing anti-inflammatory & immune-modulating drugs!

The research led by Mr Omar Pathmanaban (Strategic Development lead, Neurosurgeon) and Dr Gareth Evans (World renowned NF2 expert and NF2 BioSolutions UK & Europe charity trustee), will be conducted by 2 PhD studentships funded by NF2 BioSolutions UK & Europe.

Learn more below!

Today is NF2 Awareness Day and NF2 BioSolutions UK & Europe has incredible news for all those affected by NF2!

NF2 BioSolutions UK & Europe, together with NF2 BioSolutions, are excited to announce a new transatlantic partnership with researchers at the newly opened Geoffrey Jefferson Brain Research Centre (GJBRC) to support research into the role of inflammation in NF2 tumour growth (Schwannomas and Meningiomas)

There is a real potential that this research will lead to new treatments for those affected by NF2 by repurposing existing anti-inflammatory & immune-modulating drugs!

The research led by Mr Omar Pathmanaban (Strategic Development lead, Neurosurgeon) and Dr Gareth Evans (World renowned NF2 expert and NF2 BioSolutions UK & Europe charity trustee), will be conducted by 2 PhD studentships funded by NF2 BioSolutions UK & Europe.

Learn more below!

Don’t forget Drug Repurposing for Rare Diseases 2021 is happening in a few short weeks!

Join us virtually on the 15th – 16th June to discover the best examples of repurposing in the field of rare diseases.

Registration is NOW OPEN and is FREE for everyone. Register for the sessions that interest you most and get ready to attend them on Swapcard soon. Attendees will enjoy interactive breakout rooms and workshops to facilitate engagement, and built-in networking opportunities to replicate that in-person experience we all miss.

At the current rate of drug development, it would take 500 years to get treatments for every condition. Drug repurposing offers a quick, cheap, accessible and patient-friendly route to develop new treatments for rare diseases.

Claim your free ticket now and we’ll see you soon!

 

News

NF2 BioSolutions UK & Europe and NF2 BioSolutions announce a new transatlantic partnership!

by Blayne Baker time to read: 3 min
0